Aug 22 (Reuters) - Scandinavian ChemoTech AB
CMOTECb.ST :
* TO LEAVE DISTRIBUTOR STRATEGY
* TO DRIVE BUSINESS DEVELOPMENT AND CLINICAL SUPPORT
IN-HOUSE,
WHICH WILL ALSO POSITIVELY AFFECT COMPANY'S MARGINS
* OUR GOAL OF 50 INSTALLED VETIQURE TSE SYSTEMS BEFORE END
OF 2024
REMAINS, WHILE MARGIN WILL DEVELOP IN POSITIVE DIRECTION
* LATEST DEVELOPMENTS IN ANIMAL CARE AND ABOVE ALL IN USA
ARE
SIGNIFICANTLY BETTER THAN EXPECTED
Source text for Eikon: ID:nWkr960Z30
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))